CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) announced it granted equity awards on June 15, 2025, to 36 new non-executive employees under Madrigal’s 2023 Inducement Plan. The awards were approved by Madrigal’s independent Compensation Committee in line with Nasdaq Listing Rule 5635(c)(4).
These equity awards were given as an incentive for employees joining the company. The new hires received options to purchase 2,184 shares of Madrigal’s common stock and 21,125 time-based restricted stock units. The options have an exercise price of $295.57 per share, equal to the closing price on the grant date, and vest as follows: (i) 25% on the first anniversary of the grant date and (ii) 6.25% quarterly thereafter. Restricted stock units vest in four equal installments annually over four years. All vesting is contingent on continued employment on the vesting dates.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.